期刊
JOURNAL OF CHROMATOGRAPHY B
卷 748, 期 1, 页码 269-279出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/S0378-4347(00)00360-1
关键词
structural elucidation; BW935U83; HIV-1 reverse-transcriptase inhibitor
The human in vivo metabolism of the HIV-1 reverse transcriptase inhibitor 5-chloro-1-(2',3'-dideoxy-3'-fluoro-erythro-pentofuranosyl)uracil (BW935U83) was studied using F-19 NMR spectroscopy, directly coupled LC-NMR and LC-NMR-MS. The number and relative proportions of the drug metabolites were obtained from F-19 NMR spectra of whole human urine. The novel use of the continuous-flow F-19 detected LC-NMR experiment yielded chromatographic retention times and F-19 chemical shifts for the parent drug, the glucuronide conjugate of the parent and an early eluting polar metabolite. The parent drug and its glucuronide conjugate were easily characterised by directly coupled H-1 LC-NMR spectroscopy and two-dimensional TOCSY experiments. The identification of the second metabolite was achieved using F-19 NMR and directly coupled H-1 LC-NMR-MS which furnished the molecular weight, and through the use of MS-MS techniques, information on the fragment ions. This species was identified as 3-fluoro-ribolactone. (C) 2000 Elsevier Science B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据